MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 206 filers reported holding MEDICINES CO in Q3 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $27,630,000 | +134.2% | 325,297 | +37.8% | 0.21% | +135.2% |
Q3 2019 | $11,800,000 | +303.8% | 236,002 | +194.5% | 0.09% | +333.3% |
Q2 2019 | $2,922,000 | +219.3% | 80,128 | +144.8% | 0.02% | +162.5% |
Q1 2019 | $915,000 | +129.9% | 32,733 | +57.3% | 0.01% | +100.0% |
Q4 2018 | $398,000 | -55.4% | 20,815 | -30.3% | 0.00% | -33.3% |
Q3 2018 | $893,000 | -54.0% | 29,870 | -43.5% | 0.01% | -45.5% |
Q2 2018 | $1,941,000 | +217.7% | 52,900 | +323.2% | 0.01% | +120.0% |
Q1 2017 | $611,000 | -47.5% | 12,500 | -59.4% | 0.01% | -16.7% |
Q3 2016 | $1,163,000 | +305.2% | 30,808 | +241.3% | 0.01% | +200.0% |
Q1 2016 | $287,000 | -90.5% | 9,027 | -88.9% | 0.00% | -88.2% |
Q4 2015 | $3,035,000 | +629.6% | 81,300 | +642.5% | 0.02% | +750.0% |
Q3 2015 | $416,000 | +68.4% | 10,950 | +26.8% | 0.00% | +100.0% |
Q2 2015 | $247,000 | -91.6% | 8,633 | -91.7% | 0.00% | -93.8% |
Q1 2015 | $2,929,000 | +463.3% | 104,556 | +675.9% | 0.02% | +433.3% |
Q4 2013 | $520,000 | – | 13,476 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |